BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mirabelli C, Wotring JW, Zhang CJ, McCarty SM, Fursmidt R, Pretto CD, Qiao Y, Zhang Y, Frum T, Kadambi NS, Amin AT, O'Meara TR, Spence JR, Huang J, Alysandratos KD, Kotton DN, Handelman SK, Wobus CE, Weatherwax KJ, Mashour GA, O'Meara MJ, Chinnaiyan AM, Sexton JZ. Morphological cell profiling of SARS-CoV-2 infection identifies drug repurposing candidates for COVID-19. Proc Natl Acad Sci U S A 2021;118:e2105815118. [PMID: 34413211 DOI: 10.1073/pnas.2105815118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Ramezankhani R, Solhi R, Chai YC, Vosough M, Verfaillie C. Organoid and microfluidics-based platforms for drug screening in COVID-19. Drug Discov Today 2021:S1359-6446(21)00565-1. [PMID: 34954328 DOI: 10.1016/j.drudis.2021.12.014] [Reference Citation Analysis]
2 Caldera-Crespo LA, Paidas MJ, Roy S, Schulman CI, Kenyon NS, Daunert S, Jayakumar AR. Experimental Models of COVID-19. Front Cell Infect Microbiol 2021;11:792584. [PMID: 35096645 DOI: 10.3389/fcimb.2021.792584] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kornhuber J, Hoertel N, Gulbins E. The acid sphingomyelinase/ceramide system in COVID-19. Mol Psychiatry 2021. [PMID: 34608263 DOI: 10.1038/s41380-021-01309-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Lin T, Dadmohammadi Y, Davachi SM, Torabi H, Li P, Pomon B, Meletharayil G, Kapoor R, Abbaspourrad A. Improvement of lactoferrin thermal stability by complex coacervation using soy soluble polysaccharides. Food Hydrocolloids 2022. [DOI: 10.1016/j.foodhyd.2022.107736] [Reference Citation Analysis]
5 Gruden Š, Poklar Ulrih N. Diverse Mechanisms of Antimicrobial Activities of Lactoferrins, Lactoferricins, and Other Lactoferrin-Derived Peptides. Int J Mol Sci 2021;22:11264. [PMID: 34681923 DOI: 10.3390/ijms222011264] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Ezeonwumelu IJ, Garcia-Vidal E, Ballana E. JAK-STAT Pathway: A Novel Target to Tackle Viral Infections. Viruses 2021;13:2379. [PMID: 34960648 DOI: 10.3390/v13122379] [Reference Citation Analysis]
7 Liberti DC, Morrisey EE. Organoid models: assessing lung cell fate decisions and disease responses. Trends Mol Med 2021;27:1159-74. [PMID: 34674972 DOI: 10.1016/j.molmed.2021.09.008] [Reference Citation Analysis]
8 Zhao C, Chen N, Ashaolu TJ. Whey proteins and peptides in health-promoting functions – A review. International Dairy Journal 2022;126:105269. [DOI: 10.1016/j.idairyj.2021.105269] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
9 Aherfi S, Pradines B, Devaux C, Honore S, Colson P, Scola B, Raoult D. Drug repurposing against SARS-CoV-1, SARS-CoV-2 and MERS-CoV. Future Microbiol 2021;16:1341-70. [PMID: 34755538 DOI: 10.2217/fmb-2021-0019] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wotring JW, Fursmidt R, Ward L, Sexton JZ. Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern. Journal of Dairy Science 2022. [DOI: 10.3168/jds.2021-21247] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
11 Gligorijevic N, Radomirovic M, Nedic O, Stojadinovic M, Khulal U, Stanic-Vucinic D, Cirkovic Velickovic T. Molecular Mechanisms of Possible Action of Phenolic Compounds in COVID-19 Protection and Prevention. Int J Mol Sci 2021;22:12385. [PMID: 34830267 DOI: 10.3390/ijms222212385] [Reference Citation Analysis]
12 Bartolomé F, Rosa L, Valenti P, Lopera F, Hernández-Gallego J, Cantero JL, Orive G, Carro E. Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients. Front Immunol 2022;13:878201. [PMID: 35547737 DOI: 10.3389/fimmu.2022.878201] [Reference Citation Analysis]
13 Barros CA, Sanches D, Marques de Carvalho CA, Santos RA, Ferraz de Souza TL, Macena Leite VL, Pereira da Costa Campos S, Cheble de Oliveira A, Gonçalves RB. Influence of iron binding in the structural stability and cellular internalization of bovine lactoferrin. Heliyon 2021;7:e08087. [PMID: 34632151 DOI: 10.1016/j.heliyon.2021.e08087] [Reference Citation Analysis]
14 Mathez G, Cagno V. Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing. Antivir Chem Chemother 2021;29:20402066211061063. [PMID: 34806440 DOI: 10.1177/20402066211061063] [Reference Citation Analysis]
15 Dastjerdi S, Malikan M, Akgöz B, Civalek Ö, Wiczenbach T, Eremeyev VA. On the deformation and frequency analyses of SARS-CoV-2 at nanoscale. Int J Eng Sci 2022;170:103604. [PMID: 34728858 DOI: 10.1016/j.ijengsci.2021.103604] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Gallo V, Giansanti F, Arienzo A, Antonini G. Antiviral properties of whey proteins and their activity against SARS-CoV-2 infection. J Funct Foods 2022;89:104932. [PMID: 35003332 DOI: 10.1016/j.jff.2022.104932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Sayers EJ, Palmer I, Hope L, Hope P, Watson P, Jones AT. Fluid-Phase Endocytosis and Lysosomal Degradation of Bovine Lactoferrin in Lung Cells. Pharmaceutics 2022;14:855. [DOI: 10.3390/pharmaceutics14040855] [Reference Citation Analysis]
18 Pickard A, Calverley BC, Chang J, Garva R, Gago S, Lu Y, Kadler KE. Discovery of re-purposed drugs that slow SARS-CoV-2 replication in human cells. PLoS Pathog 2021;17:e1009840. [PMID: 34499689 DOI: 10.1371/journal.ppat.1009840] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Pang Z, Hu R, Tian L, Lou F, Chen Y, Wang S, He S, Zhu S, An X, Song L, Liu F, Tong Y, Fan H. Overview of Breastfeeding Under COVID-19 Pandemic. Front Immunol 2022;13:896068. [PMID: 35711421 DOI: 10.3389/fimmu.2022.896068] [Reference Citation Analysis]
20 Yin Z, Wong STC. Artificial intelligence unifies knowledge and actions in drug repositioning. Emerg Top Life Sci 2021;5:803-13. [PMID: 34881780 DOI: 10.1042/ETLS20210223] [Reference Citation Analysis]
21 Zhou YH, Luo Y, Xiang K. Thinking More About Inhibition of Breast Milk on the Infectivity of SARS-CoV-2. JAMA Pediatr 2022. [PMID: 35226049 DOI: 10.1001/jamapediatrics.2021.6613] [Reference Citation Analysis]
22 Herold R, Scholtysik R, Moroniak S, Weiss C, Ishikawa H, Schroten H, Schwerk C. Capsule-dependent impact of MAPK signalling on host cell invasion and immune response during infection of the choroid plexus epithelium by Neisseria meningitidis. Fluids Barriers CNS 2021;18:53. [PMID: 34863201 DOI: 10.1186/s12987-021-00288-7] [Reference Citation Analysis]
23 Ostrov DA, Bluhm AP, Li D, Khan JQ, Rohamare M, Rajamanickam K, K Bhanumathy K, Lew J, Falzarano D, Vizeacoumar FJ, Wilson JA, Mottinelli M, Kanumuri SRR, Sharma A, McCurdy CR, Norris MH. Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. Pathogens 2021;10:1514. [PMID: 34832669 DOI: 10.3390/pathogens10111514] [Reference Citation Analysis]
24 Ahamad S, Ali H, Secco I, Giacca M, Gupta D. Anti-Fungal Drug Anidulafungin Inhibits SARS-CoV-2 Spike-Induced Syncytia Formation by Targeting ACE2-Spike Protein Interaction. Front Genet 2022;13:866474. [PMID: 35401674 DOI: 10.3389/fgene.2022.866474] [Reference Citation Analysis]
25 Young BE, Järvinen KM, Seppo A. Thinking More About Inhibition of Breast Milk on the Infectivity of SARS-CoV-2-Reply. JAMA Pediatr 2022. [PMID: 35226051 DOI: 10.1001/jamapediatrics.2021.6616] [Reference Citation Analysis]
26 Chan WKB, Olson KM, Wotring JW, Sexton JZ, Carlson HA, Traynor JR. In silico analysis of SARS-CoV-2 proteins as targets for clinically available drugs. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-08320-y] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
27 Willmer AR, Nie J, De la Rosa MVG, Wen W, Dunne S, Rosania GR. Molecular design of a pathogen activated, self-assembling mechanopharmaceutical device. J Control Release 2022:S0168-3659(22)00292-9. [PMID: 35623493 DOI: 10.1016/j.jconrel.2022.05.029] [Reference Citation Analysis]